Viewing Study NCT00449462



Ignite Creation Date: 2024-05-05 @ 5:24 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00449462
Status: COMPLETED
Last Update Posted: 2007-07-06
First Post: 2007-03-19

Brief Title: Effect of Conjugated Linoleic Acid Intake on Liver and Kidney Function
Sponsor: Wageningen University
Organization: Wageningen University

Study Overview

Official Title: The Effect of Conjugated Linoleic Acid Intake on Liver and Kidney Function in Healthy Volunteers CLAxon-Study
Status: COMPLETED
Status Verified Date: 2007-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The knowledge of the health effects of CLA on the human body is limited However CLA supplements are sold over the counter in several countries and various techniques are used to increase the content of CLA in food

The CLAxon-study will be performed to investigate wether high doses of CLA can be safely given to healthy human volunteers
Detailed Description: Each volunteer receives CLA enriched products for a total of 3 weeks containing approximately 20g CLA per day A control group is not needed If three subjects or more show one or more blood values for liver and kidney function above predefined limits the study will be terminated

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None